StemCellRegenMed - Stem Cell Treatments

RHEUMATOID ARTHRITIS

Rheumatoid arthritis is a disabling disorder related to immune dysfunction and autoantibodies that often involves multiple joints that may include knees, ankles, hips, shoulders, elbows and the spine. Patients with rheumatoid arthritis and chronic degenerative cartilage joint disease that is severe and unresponsive to standard therapy should consider the use of stem cells. This would include those patients that have chronic pain in multiple joints; marked swelling of joints; disabling arthritis of the spine; patients that have restrictions in using their hands or walking.

Osteoarthritis is caused by misuse or chronic trauma to a joint. It generally may involve less generalized involvement of joints; often solitary.

Treatments include anti-inflammatories and steroids that will temporary relief of symptoms. Severe chronic disease may result in needing joint surgical replacements.

Therapy from StemCellRegenMed involves the following:

Autologous stem cells derived from the patient’s own bone marrow or peripheral blood are given intravenously or directly into the affected joint(s).
Stem cells derived from umbilical cord blood are pluripotent and can form cell lines that are more effective. Patients can be given precursor cartilage cells called chrondrocytes that are can be given intravenously or into effected joints. In addition patients can be given immunological dendritic stem cells that will interfere with autoimmune antibodies that damage joints in rheumatoid arthritis. The basic biology for this therapy is putting umbilical cord into culture with specific growth factors and nutrients that program the cells to form chrondrocytes and dendritic cells that become the basis for the treatment.

Medical Disclaimer: Treatments discussed on this website are experimental and have not been approved by the FDA. No guarantees are made regarding the results of these treatments. Prospective patients are advised to discuss the use of a Stem Cell treatment for their disease with their physician.


		RHEUMATOID ARTHRITIS Rheumatoid arthritis is a disabling disorder related to immune dysfunction and autoantibodies that often involves multiple joints that may include knees, ankles, hips, shoulders, elbows and the spine. Patients with rheumatoid arthritis and chronic degenerative cartilage joint disease that is severe and unresponsive to standard therapy should consider the use of stem cells. This would include those patients that have chronic pain in multiple joints; marked swelling of joints; disabling arthritis of the spine; patients that have restrictions in using their hands or walking. Osteoarthritis is caused by misuse or chronic trauma to a joint. It generally may involve less generalized involvement of joints; often solitary. Treatments include anti-inflammatories and steroids that will temporary relief of symptoms. Severe chronic disease may result in needing joint surgical replacements. Therapy from StemCellRegenMed involves the following: Autologous stem cells derived from the patient’s own bone marrow or peripheral blood are given intravenously or directly into the affected joint(s). Stem cells derived from umbilical cord blood are pluripotent and can form cell lines that are more effective. Patients can be given precursor cartilage cells called chrondrocytes that are can be given intravenously or into effected joints. In addition patients can be given immunological dendritic stem cells that will interfere with autoimmune antibodies that damage joints in rheumatoid arthritis. The basic biology for this therapy is putting umbilical cord into culture with specific growth factors and nutrients that program the cells to form chrondrocytes and dendritic cells that become the basis for the treatment. Medical Disclaimer: Treatments discussed on this website are experimental and have not been approved by the FDA. No guarantees are made regarding the results of these treatments. Prospective patients are advised to discuss the use of a Stem Cell treatment for their disease with their physician.